Conclusions
The multivalency of cold-reactive IgM anti-lymphocyte autoantibodies, together with the local density of reactive antigens on the cell surface, may confer a capacity for a variety of immunoregulatory and non-specific physiological roles in the immune system and in SLE and other autoimmune diseases. Targets of interest in this regard include CD45, β 2 microglobulin, and surface immunoglobulin. IgG anti-lymphocyte autoantibodies, while more difficult to study, also exhibit interesting specificities. However, whether any of the mechanisms by which anti-lymphocyte autoantibodies could alter cellular function actually obtain in vivo remains speculative. Essentially all of the data in this regard derive from experiments in which anti-lymphocyte autoantibody-containing SLE serum or plasma, or purified Ig fractions thereof, is combined with peripheral blood mononuclear cells in short-term culture in vitro. Thus, it is possible that anti-lymphocyte autoantibodies in SLE, rather than contributing to pathogenesis, reflect a physiological attempt by the immune system to restore homeostasis in the face of aggressive autoimmune stimulation.
Similar content being viewed by others
References
Anderson CL, Stillman WS (1980) Raji assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. J Clin Invest 66:353
Arend WP, Emmerich TE, Sturge JC, Starkebaum GA (1977) Monocyte-reactive antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 20:1049
Bell EB (1992) Function of CD4 T cell subsets in vivo: expression of CD45R isoforms. Semin Immunol 4:43
Beverley PC (1987) Human T cell subsets. Immunol Lett 14:26344
Beverley PC (1992) Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 4:35
Bluestein HG, Zvaifler NJ (1976) Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 57:509
Butler WT, Sharp JT, Rossen RD (1972) Relationship of the clinical course of systemic lupus erythematosus to the presence of circulating lymphocytotoxic antibodies. Arthritis Rheum 15:231
Chien Y-H, Davis MM (1993) How alpha beta T-cell receptors “see” peptide/MHC complexes. Immunol Today 14:597
Evavold BD, Sloan-Lancaster J, Allen PM (1993) Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 14:602
Forsyth KD, Chua K-Y, Talbot V, Thomas WR (1993) Expression of the leukocyte common antigen CD45 by endothelium. J Immunol 150:3471
Glinski W, Gershwin ME, Steinberg AD (1976) Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T cell antibodies from patients with systemic lupus erythematosus. J Clin Invest 57:604
Jacob L, Lety M-A, Louvard D, Bach J-F (1985) Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest 75:315
Kagami M, Koike T, Takabayashi K, Tomioka H, Yoshida S (1987) Antibody to activated lymphocytes in patients with systemic lupus erythematosus. J Rheumatol 14:907
Koretzky GA (1993) Role of the CD45 tyrosine phosphatase in signal transduction in the immune system. FASEB J 7:420
Kumagai S, Steinberg AD, Green I (1981) Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells. J Clin Invest 67:605
Lafer EM, Rauch J, Andrzejewski C Jr, Mudd D, Furie B, Schwartz RS, Stollar BD (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153:897
Lies RB, Messner RP, Williams RC Jr (1973) Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus. Arthritis Rheum 16:369
Litvin DA, Cohen PL, Winfield JB (1983) Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products. J Immunol 130:181
Maher GM, Hartman KR (1993) Detection of antineutrophil autoantibodies by flow cytometry: use of unfixed neutrophils as antigenic targets. J Clin Lab Anal 7:334
Marchalonis JJ, Kaymaz H, Dedeoglu F, Schluter SF, Yocum DE, Edmundson AB (1992) Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain. Proc Natl Acad Sci USA 89:3325
Marchalonis JJ, Kaymaz H, Schluter SF, Yocum DE (1993) Human autoantibodies to a synthetic putative T cell receptor β-chain regulatory idiotype: expression in autoimmunity and aging. Exp Clin Immunogenet 10:1
Marchalonis JJ, Schluter SF, Wilson L, Yocum DE, Boyer JT, Kay MMB (1993) Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease. Gerontology 39:65
Messner RP, DeHoratius RJ, Ferrone S (1980) Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives. Reactivity with the HLA antigenic molecular complex. Arthritis Rheum 23:265
Mimura T, Fernsten P, Jarjour W, Winfield JB (1990) Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus. J Exp Med 172:653
Mittal KK, Rossen RD, Sharp JT, Lidsky MD, Butler WT (1970) Lymphocyte cytotoxic antibodies in systemic lupus erythematosus. Nature 225:1255
Morimoto C, Reinherz EL, Abe T (1980) Characteristics of anti-T cell antibodies in systemic lupus erythematosus: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. Clin Immunol Immunopathol 16:474
Morimoto C, Letvin NL, Distaso JA, Aldrich WR, Schlossman SF (1985) The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 134:1508
Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Daley J, Levine H, Schlossman SF (1987) A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79:762
Noguchi M, Iwamori M, Hirano T, Kobayashi S, Hashimoto H, Hirose S, Nagai Y (1992) Autoantibodies to T and B cell lines detected in serum samples from patients with systemic lupus erythematosus with lymphopenia and hypocomplementaemia. Ann Rheum Dis 51:713
Okudaira K, Searles RP, Ceuppens JL, Goodwin JS, Williams RC Jr (1982) Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest 69:17
Ooi BS, Ooi YM, Pesce AJ, Pollak V (1977) Antibodies to β 2 microglobulin in the sera of patients with systemic lupus erythematosus. Immunology 33:535
Ozturk GE, Terasaki PI (1979) Non-HLA lymphocyte cytotoxins in various diseases. Tissue Antigens 14:52
Peake PW, Greenstein JD, Timmermans V, Gavrilovic L, Charlesworth JA (1988) Lymphocytotoxic antibodies in systemic lupus erythematosus: studies of their temperature dependence, binding characteristics, and specificity in vitro. Ann Rheum Dis 47:725
Pingel JT, Thomas ML (1989) Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58:1055
Pischel KD, Bluestein HG, Woods VL Jr (1984) Molecular characterization of lymphocyte cell surface proteins reactive with systemic lupus erythematosus (SLE) autoantibodies. Arthritis Rheum 27:83
Poggi A, Pardi R, Pella N, Morelli L, Sivori S, Vitale M, Revello V, Moretta A, Moretta L (1993) CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. Eur J Immunol 23:2454
Pope RM, Keightley R, McDuffy S (1982) Circulating autoantibodies to IgD in rheumatic diseases. J Immunol 128:1860
Ramirez F, Williams RC, Sibbitt WL, Searles RP (1986) Immunogloblin from systemic lupus erythematosus serum induces interferon release by normal mononuclear cells. Arthritis Rheum 29:326
Rekvig OP (1989) Intrinsic cell membrane antigen recognized by antichromatin autoantibodies; The membrane antigens do not derive from the nucleus. Scand J Immunol 29:7
Rekvig OP, Hannestad K (1977) Certain polyclonal anti-nuclear antibodies cross-react with the surface membrane of human lymphocytes and granulocytes. Scand J Immunol 6:1041
Rekvig OP, Hannestad K (1979) The specificity of human autoantibodies that react with both cell nuclei and plasma membranes: the nuclear antigen is present on core mononucleosomes. J Immunol 123:2673
Revillard JP, Vincent C, Rivera S (1979) Anti-β 2 microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. J Immunol 122:614
Rook AH, Tsokos GC, Quinnan GV Jr, Balow JE, Ramsey KM, Stocks N, Phelan MA, Djeu JY (1982) Cytotoxic antibodies to natural killer cells in systemic lupus erythematosus. Clin Immunol Immunopathol 24:179
Sakane T, Steinberg AD, Reeves JP, Green I (1979) Studies of immune functions of patients with systemic lupus erythematosus. J Clin Invest 63:954
Sakane T, Steinberg AD, Reeves JP, Green I (1979) Studies of immune functions of patients with systemic lupus erythematosus: T-cell subsets and antibodies to T-cell subsets. J Clin Invest 64:1260
Sakane T, Kotani H, Takada S, Murakawa Y, Ueda Y (1983) A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. J Immunol 131:753
Steinberg AD, Klassen LW, Budman DR, Williams GW (1979) Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining cells in active disease. Arthritis Rheum 22:114
Takahashi H, Terasaki PI, Iwaki Y, Nakata S (1980) Identification of surface IgM as the target antigen of cold lymphocytotoxins. Tissue Antigens 16:176
Takeuchi T, Abe T, Kiyotaki M, Toguchi T, Koide J, Morimoto C, Homma M (1982) In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation. Scand J Immunol 16:369
Takeuchi T, Rudd CE, Schlossman SF, Morimoto C (1987) Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen. Eur J Immunol 17:97
Takeuchi T, Tanaka S, Steinberg AD, Matsuyama T, Daley J, Schlossman SF, Morimoto C (1988) Defective Expression of the 2H4 Molecule after autologous mixed lymphocyte reaction activation in systemic lupus erythematosus patients. J Clin Invest 82:1288
Tanaka S, Matsuyama T, Steinberg AD, Schlossman SF, Morimoto C (1989) Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. Arthritis Rheum 32:398
Terasaki PI, McClelland JD (1964) Microdroplet assay of human serum cytotoxins. Nature 204:998
Terasaki PI, Mottironi VD, Barnett EV (1970) Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med 283:724
Thomas DB (1973) Antibodies specific for human T lymphocytes in cold agglutinin and lymphocytotoxic sera. Eur J Immunol 3:824
Thomas ML (1989) The leukocyte common antigen family. Annu Rev Immunol 7:339
Tonks NK, Charbonneau H, Diltz CD, Fischer EH, Walsh KA (1988) Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase. Biochemistry 27:8695
Twomey JJ, Laughter AH, Steinberg AD (1978) A serum inhibitor of immune regulation in patients with systemic lupus erythematosus (SLE). J Clin Invest 62:713
Williams RC Jr, Lies RB, Messner RP (1973) Inhibition of mixed leukocyte culture responses by serum and τ-globulin fractions from certain patients with connective tisue disorders. Arthritis Rheum 16:597
Williams RC Jr, Bankhurst AD, Montaño JD (1976) IgG anti-lymphocyte antibodies in SLE detected by 125I protein A. Arthritis Rheum 19:1261
Winfield JB, Winchester RJ, Kunkel HG (1975) Association of cold-reactive anti-lymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum 18:587
Winfield JB, Winchester RJ, Wernet P, Fu SM, Kunkel HG (1975) Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum 18:1
Winfield JB, Shaw M, Minota S (1986) Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus. J Immunol 136:3246
Winfield JB, Shaw M, Yamada A, Minota S (1987) Subset specificity of anti-lymphocyte antibodies in systemic lupus erythematosus. II. Preferential reactivity with T4+ cells is associated with relative depletion of autologous T4+ cells. Arthritis Rheum 30:162
Yamada A, Winfield JB (1984) Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus. J Clin Invest 74:1948
Yamada A, Cohen PL, Winfield JB (1985) Subset specificity of anti-lymphocyte antibodies in systemic lupus erythematosus. Preferential reactivity with cells bearing the T4 and autologous erythrocyte receptor phenotypes. Arthritis Rheum 28:262
Yamada A, Shaw M, Winfield JB (1985) Surface antigen specificity of cold-reactive IgM antilymphocyte antibodies in systemic lupus erythematosus. Arthritis Rheum 28:44
Yamada A, Minota S, Nojima Y, Yazaki Y (1993) Changes in subset specificity of anti-T cell autoantibodies in systemic lupus erythematosus. Autoimmunity 14:269
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winfield, J.B., Fernsten, P., Czyzyk, J. et al. Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus. Springer Semin Immunopathol 16, 201–210 (1994). https://doi.org/10.1007/BF00197517
Issue Date:
DOI: https://doi.org/10.1007/BF00197517